GH and IGF-I in lipoprotein metabolism

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue SUPPL. 1, 1997, Pages 137-141

  Edén, Staffan ^a   Oscarsson, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GROWTH HORMONE; INSULIN; LIPOPROTEIN; SOMATOMEDIN C;

ACROMEGALY; CONFERENCE PAPER; FAMILIAL HYPERCHOLESTEROLEMIA; GROWTH HORMONE DEFICIENCY; INSULIN RELEASE; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEIN METABOLISM; OSTEOPOROSIS;

EID: 0030906998     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.1997.10.s1.137     Document Type: Conference Paper

References (32)

1. Rosén T, Bengtsson B-Å. Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet 1990; 336: 285-288.
2. Cuneo RC, Salomon F, McGauley GA, Sönksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol 1992; 37: 387-397.
3. Bengtsson B-Å, Edén S, Ernest I, Odén A, Sjögren B. Epidemiology and long time survival of acromegaly. A study of 166 patients diagnosed 1955-1984. Acta Med Scand 1988; 223: 327-335.
4. Edén S, Wiklund O, Oscarsson J, Rosén T, Bengtsson B-Å. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arteriosclerosis and Thrombosis, 1993; 13: 296-301.
5. Rosén T, Edén S, Larsson G, Wilhelmsen L, Bengtsson B-Å. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993; 129: 195-200.
6. Cuneo RS, Salomon F, Watts GF, Hesp R, Sönksen PH. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 1993; 42: 1519-1523.
7. Angelin B, Rudling M Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipid 1994; 5: 160-165.
8. Tonstad S, Sundt E, Ose L, Hagve T-A, Fruchart J-C, Bard JM, Edén S. Does growth hormone lower low density lipoprotein cholesterol levels in familial hypercholesterolemia? Metabolism 1996, in press.
9. Froesch ER, Guler H-P, Schmid C, Binz K, Zapf J. Therapeutic potential of insulin-like growth factor I. Trends Endocrinol Metab 1990; 1: 254-260.
10. Oscarsson J, Lundstam U, Gustafsson B, Wilton P, Edén S, Wiklund O. Recombinant human insulin-like growth factor I decreases serum lipoprotein(a) concentrations in normal adult men. Clin Endocrinol 1995; 42: 673-676.
11. Olivecrona H, Johansson AG, Lindh E, Ljunghall S, Berglund L, Angelin B. Hormonal regulation of serum lipoprotein(a) levels: Contrasting effects of growth hormone and insulin-like growth factor-I. Arterioscl Throm Vasc Biol 1995; 15: 847-849.
12. Schalch DS, Turman NJ, Marcsisin VS, Heffernan M, Guler H-P. Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus. J Clin Endocrinol Metab 1993; 77: 1563-1568.
13. Zenobi PD, Holzmann P, Glatz Y, Riesen WE, Froesch ER, Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Diabetologia 1993; 36: 465-469.
14. Clemmons DR, Moses AC, Young CJS, Morrow LA, O'Brien M. Insulin sensitivity is increased in type D diabetes mellitus in response to human insulin-like growth factor I. Endocrinol Metab 1996; (Suppl A): 83-89.
15. Thorén MC, Wivall-Helleryd IL, Blum WF, Hall K. Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency. Eur J Endocrinol 1994; 131: 33-40.
16. Laron Z, Anin S, Klipper-Aurbach Y, Klinger B. Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 1992; 339: 1258-1261.
17. Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ,Gargosky S, Cohen P, Wilson K, Rosenfeld RG. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab 1993; 77: 273-280.
18. Laron Z, Klinger B. IGF-I treatment of adult patients with Laron syndrome: Preliminary results. Clin Endocrinol 1994; 41: 631-638.
19. Bewu M, Durrington PN. Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 1990: 85: 1-14.
20. Oscarsson J, Ottosson M, Wiklund O, Marin P, Vikman K, Björntorp P, Edén S. Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men. Clin Endocrinol 1994; 41: 109-116.
21. Oscarsson J, Wiklund O, Jakobsson K-E, Petruson B, Bengtsson B-Å. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy. Clin Endocrinol 1994; 41: 603-608.
22. Ottosson M. Cortisol and growth hormone regulation of human adipose tissue metabolism. Thesis. Göteborg, 1995.
23. Sjöberg A, Oscarsson J, Boström K, Innerarity TL, Edén S, Olofsson S-O. Effects of growth hormone on apolipoprotein B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology 1992; 130: 3356-3364.
24. Sjöberg A, Oscarsson J, Edén S, Olofsson S-O. Continuous but not intermittent administration of growth hormone to hypophysectomized rats increases apolipoprotein-E secretion from cultured hepatocytes. Endocrinology 1994; 134: 790-798.
25. Sjöberg A, Oscarsson J, Borén J, Edén S, Olofsson S-O. Mode of growth hormone administration influences triacylglycerol synthesis and assembly of apolipoprotein B containing lipoproteins in cultured rat hepatocytes. J Lipid Res 1996; 37: 275-279.
26. Rudling M, Norstedt G, Olivercrona H, Reinér E, Gustafsson J-Å, Angelin B. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 1992; 89: 6983-6987.
27. Olivecrona H. On the hormonal regulation of hepatic cholesterol and lipoprotein metabolism. Thesis. Karolinska Institute, 1995.
28. Vikman K, Oscarsson J, Nilsson-Ehle P, Edén S. Growth hormone but not gonadal steroids influence lipoprotein lipase and hepatic lipase activity in hypophysectomized rats. J Endocrinol 1994; 140: 203-209.
29. Vikman-Adolfsson K. Growth hormone and IGF-I in the regulation of lipoprotein lipase in the rat. Thesis. Göteborg, 1996.
30. Sjöberg A, Oscarsson J, Olofsson S-O, Edén S. Insulin-like growth factor-I and growth hormone treatment have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes. Endocrinology 1994; 135: 1415-1421.
31. Rudling M, Olivecrona H, Eggertsen G, Angelin B. Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I. J Clin Invest 1996; 97: 292-299.
32. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, Palmiter RD. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 1989; 124: 40-48.